QUATTRONE, ALDO
 Distribuzione geografica
Continente #
AS - Asia 11.968
NA - Nord America 5.696
EU - Europa 2.161
SA - Sud America 2.073
AF - Africa 206
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 1
Totale 22.119
Nazione #
US - Stati Uniti d'America 5.438
SG - Singapore 5.059
CN - Cina 2.644
BR - Brasile 1.707
HK - Hong Kong 1.182
VN - Vietnam 1.145
FR - Francia 705
KR - Corea 518
JP - Giappone 430
IT - Italia 424
NL - Olanda 272
IN - India 207
BD - Bangladesh 191
GB - Regno Unito 156
DE - Germania 147
AR - Argentina 122
CA - Canada 111
FI - Finlandia 99
ID - Indonesia 86
IL - Israele 77
EC - Ecuador 76
MX - Messico 67
ZA - Sudafrica 62
IQ - Iraq 51
TR - Turchia 46
UA - Ucraina 44
CO - Colombia 43
SA - Arabia Saudita 42
PL - Polonia 41
ES - Italia 38
UZ - Uzbekistan 38
PK - Pakistan 35
RU - Federazione Russa 34
PY - Paraguay 33
KE - Kenya 30
CL - Cile 29
MA - Marocco 28
SE - Svezia 28
PH - Filippine 27
VE - Venezuela 27
AT - Austria 26
MY - Malesia 24
TH - Thailandia 23
IE - Irlanda 19
AE - Emirati Arabi Uniti 17
PE - Perù 17
EG - Egitto 16
HN - Honduras 13
KZ - Kazakistan 13
TT - Trinidad e Tobago 13
AL - Albania 12
DZ - Algeria 12
JM - Giamaica 12
UY - Uruguay 12
NP - Nepal 11
RO - Romania 11
TN - Tunisia 11
AZ - Azerbaigian 10
DO - Repubblica Dominicana 10
LV - Lettonia 9
OM - Oman 9
DK - Danimarca 8
JO - Giordania 8
KW - Kuwait 8
LT - Lituania 8
PS - Palestinian Territory 8
BY - Bielorussia 7
GE - Georgia 7
SN - Senegal 7
AU - Australia 6
BO - Bolivia 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
LB - Libano 6
LK - Sri Lanka 6
NI - Nicaragua 6
PT - Portogallo 6
RS - Serbia 6
BG - Bulgaria 5
BH - Bahrain 5
CH - Svizzera 5
GR - Grecia 5
KG - Kirghizistan 5
QA - Qatar 5
TW - Taiwan 5
BA - Bosnia-Erzegovina 4
ET - Etiopia 4
HR - Croazia 4
HU - Ungheria 4
IR - Iran 4
LA - Repubblica Popolare Democratica del Laos 4
MD - Moldavia 4
MK - Macedonia 4
NZ - Nuova Zelanda 4
PA - Panama 4
AM - Armenia 3
BE - Belgio 3
EE - Estonia 3
GT - Guatemala 3
MM - Myanmar 3
Totale 22.044
Città #
Singapore 2.944
Santa Clara 2.283
Hong Kong 1.163
Hefei 1.152
San Jose 626
Lauterbourg 547
Seoul 513
Beijing 449
Ho Chi Minh City 426
Tokyo 353
Ashburn 348
Hanoi 262
Los Angeles 240
Dallas 135
New York 135
São Paulo 133
Buffalo 106
Helsinki 71
Minamishinagawa 68
Orem 67
Da Nang 54
Frankfurt am Main 48
Bengaluru 47
Rio de Janeiro 44
Montreal 42
Haiphong 41
Belo Horizonte 40
Milan 37
Boardman 35
Curitiba 32
Rome 32
Tashkent 31
Warsaw 31
Amsterdam 30
London 30
Naples 30
Brooklyn 29
Porto Alegre 29
Brasília 27
Biên Hòa 26
Paris 26
Atlanta 24
Baghdad 24
Chicago 24
Johannesburg 24
Quito 24
Guayaquil 23
Jakarta 23
Nuremberg 23
Phoenix 23
Chennai 22
Nairobi 22
Dhaka 21
Mumbai 21
Turku 21
Bangkok 20
Goiânia 20
Campinas 19
Salvador 19
San Francisco 19
Thái Bình 19
Toronto 18
Can Tho 17
Guarulhos 17
Manchester 17
Stockholm 17
Asunción 16
Dublin 16
Newark 16
Thái Nguyên 16
Turin 16
Cape Town 15
Denver 15
Fortaleza 15
Guangzhou 15
Recife 15
Riyadh 15
Buenos Aires 14
Council Bluffs 14
Düsseldorf 14
Hải Dương 14
Manaus 14
Munich 14
New Delhi 14
Shanghai 14
Ankara 13
Florianópolis 13
Mexico City 13
Nha Trang 13
Houston 12
Kyiv 12
Lahore 12
Phủ Lý 12
Ribeirão Preto 12
Bắc Ninh 11
Cairo 11
City of London 11
Colombo 11
Jeddah 11
Juiz de Fora 11
Totale 13.743
Nome #
Dropped head syndrome in a patient with FTD-ALS caused by abnormal expansion of C9orf72 gene. 113
A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study 100
MR parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP-parkinsonism. 92
Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer's Disease 91
Multiple system atrophy and C9orf72 hexanucleotide repeat expansions in a cohort of Italian patients 89
A SLC20A2 mutation identified in an asymptomatic patient with brain calcification 87
A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease. 87
Color vision as a biological marker able to differentiate two phenotypically similar neurological diseases 85
Lack of interaction between LRP1 and A2M polymorphisms for the risk of Alzheimer disease. 84
Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis 83
G-463A myeloperoxidase polymorphism and parkinson s disease 83
The motor inhibition system in Parkinson's disease with levodopa-induced dyskinesias. 80
NOS2A AS CANDIDATE GENE IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: AN HAPLOTYPE STUDY BY USING A SUBSETS OF SNPs. 79
Mutational screening of the eIF2B5 gene in sib pairs affected by multiple sclerosis. 78
Contribution of Cerebrospinal Fluid Thymosin beta 4 Levels to the Clinical Differentiation of Creutzfeldt-Jakob Disease 78
Ataxia with oculomotor apraxia in a family from southern italy : a clinical and genetic study 77
Coadministration of entacapone with levodopa attenuates severità of wearing off in PD patients. 77
Conventional MRI and NOTCH3 gene screening in sporadic CADASIL. 77
ANALYSIS OF SMN1 GENE COPY NUMBER TO DETECT SMA HEALTH CARRIERS IN SOUTHERN ITALY POPULATION 72
Automated MRI Classification in Progressive Supranuclear Palsy: a Large International Cohort Study 72
Serotonin receptor 2a gene variant influences age at onset but not cognitive performance in patients with temporal lobe epilepsy. 71
Disturbo di Alzheimer e tono dell'umore 71
Refining initial diagnosis of Parkinson's disease after follow-up: A 4-year prospective clinical and magnetic resonance imaging study. 71
Serotonin transporter gene (5-Htt): association analysis with temporal lobe epilepsy. 70
ASSOCIATION STUDY BETWEEN THE LINGO1 GENE AND PARKINSON S DISEASE IN THE ITALIAN POPULATION 70
Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: Which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease? 70
Gene Symbol: MECP2. Disease: Rett Syndrome. 69
Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease 69
Seizures and epilepsy in neurofibromatosis type 1 (NF1): a genotype-phenotype study. 68
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry 68
Alpha synuclein in familial parkinson s disease and lewy body dementia. 67
Two Novel Cysteine-Sparing Notch3 Mutations In Patients With CADASIL 67
MR imaging and cognitive correlates of relapsing-remitting multiple sclerosis patients with cerebellar symptoms. 66
Mutational Screening in Patient with Charcot-Marie-Tooth Disease Type 2A 65
The effects of BDNF Val(66)Met polymorphism on brain function in controls and patients with multiple sclerosis: An imaging genetic study. 63
Anti-N-methyl-D-aspartate-glutamic-receptor encephalitis presenting as paroxysmal exercise-induced foot weakness. 63
Unilateral basal ganglia atrophy in a patient with tuberous sclerosis complex and hemichorea 63
Magnetic Resonance Imaging Biomarkers Distinguish Normal Pressure Hydrocephalus From Progressive Supranuclear Palsy. 63
Investigation of the relationship between anti-GM1 antibodies and brain atrophy in multiple sclerosis 62
Molecular studies of the PANK2 gene in patients with PKAN 62
Influence of functional polymorphism in MAO-A on neural network responsible of spatial working memory 61
Comparative study between western blotting and ELISA for the determination of anti-MBP antibodies in serum of patients with Multiple Sclerosis 60
Parkinson's disease, Parkinsonism, De novo Parkinson's disease, Essential tremor: a color vision preliminary analysis 60
Reproductive factors and Parkinson's disease: A multicenter case-control study. 60
Color vision analysis as an eligible method to study the progression of type 2 diabetes 60
Leber's hereditary optic neuropathy associated with a multiple-sclerosis-like picture in a man 60
CSF opening pressure: reference interval and the effect of body mass index 59
Altered cortical-cerebellar circuits during verbal working memory in essential tremor 59
Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease a multicenter study. 59
Hippocampal subfield atrophies in converted and not-converted mild cognitive impairments patients by a Markov random fields algorithm 59
Lack of association between G-protein coupled receptor kinase 5 gene and Parkinson's disease 59
Archibald Edward Garrod and Alcaptonuria: Inborn errors of metabolism revisited 58
Blink re fl ex recovery cycle distinguishes essential tremor with resting tremor from de novo Parkinson ' s disease: An exploratory study 58
Hyper-religiosity and visual hallucinations in a patient with frontotemporal dementia carrying a double variant in GRN gene 58
MRI measurements predict PSP in unclassifiable parkinsonisms: A cohort study 58
Neurofunctional correlates of cognitive impairment in essential tremor 57
Microstructural changes in normal-appearing white matter in male sleep apnea patients are reversible after treatment: A pilot study 56
Individual differences in depression are associated with abnormal function of the limbic system in multiple sclerosis patients. 56
Increased cerebellar gray matter volume in head chefs. 56
Evaluation of machine learning algorithms performance for the prediction of early multiple sclerosis from resting-state FMRI connectivity data. 56
Genetic analysis of SCA2 and SCA17 in familial Parkinson s disease. 55
CAV3 T78M MUTATION IN HETEROZYGOSIS IS NOT ASSOCIATED WITH LGMD1C IN SOUTHERN ITALY 55
A Machine Learning Approach for Detecting Idiopathic REM Sleep Behavior Disorder 55
A novel locus for dHMN with pyramidal features maps to chromosome 4q34.3-q35.2. 54
Microstructural changes of normal-appearing white matter in Vascular Parkinsonism 54
Refining initial diagnosis of Parkinson's disease after follow-up: A 4-year prospective clinical and magnetic resonance imaging study 54
Random Forest Algorithm for the Classification of Neuroimaging Data in Alzheimer's Disease: A Systematic Review 54
Thalamic neurometabolic alterations in tremulous Parkinson's disease: A preliminary proton MR spectroscopy study. 54
Cerebellar involvement in essential tremor with and without resting tremor: A Diffusion Tensor Imaging study 54
The challenge of mapping the human connectome based on diffusion tractography 54
Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study 54
Tremor pattern differentiates drug-induced resting tremor from Parkinson disease 53
Color vision impairment: a preliminar comparison among Idiopathic Prkinson, Essential Tremor, Parkinsonism, Early Parkinson's Disease 53
Diffusion tensor MRI changes in cerebellar structures of patients with familial essential tremor. 53
Alpha-synuclein promoter haplotypes and dementia in Parkinson's disease. 52
Clinical and genetic study of an Italian family linked to SPG26 locus 52
"Schwann cells", a historical landmark in neurology 52
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. 52
Impair acquired color vision in multiple sclerosis: an early diagnostic sign linked to the greatness of disease 52
Automatic Detection of White Matter Hyperintensities in Healthy Aging and Pathology Using Magnetic Resonance Imaging: A Review. 52
Gene symbol: NOTCH3 51
DESCRIPTION OF A FOUR-GENERATION FAMILY WITH AUTOSOMAL DOMINANT CEREBELLAR ATAXIA: CLINICAL AND GENETIC ANALYSIS 51
FUS mutations in sporadic amyotrophic lateral sclerosis: clinical and genetic analysis. 51
Increased glutamate + glutamine levels in the thalamus of patients with essential tremor: A preliminary proton MR spectroscopic study 51
Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease. 51
Development of a New Wearable Device for the Characterization of Hand Tremor 51
Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration 51
DJ-1 gene confers susceptibility to Parkinson s disease. 50
A family with dominant optic atrophy and deafness due to a novel Opa1 mutation. 50
The DRD2 TaqIA polymorphism associated with changed midbrain volumes in healthy individuals. 50
A Fully Automated, Atlas-Based Approach for Superior Cerebellar Peduncle Evaluation in Progressive Supranuclear Palsy Phenotypes. 50
The discovery of beri-beri and scurvy vitamins - two hundred and two years from its discovery. 50
Blink reflex recovery cycle distinguishes patients with idiopathic normal pressure hydrocephalus from elderly subjects 50
Video-oculographic biomarkers for evaluating vertical ocular dysfunction in progressive supranuclear palsy 50
Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study 50
The corticospinal tract profile in amyotrophic lateral sclerosis. 50
Aceruloplasminemia: a multimodal imaging study in an Italian family with a novel mutation 50
Wearable Devices for Assessment of Tremor. 49
Thymosin beta 4 is overexpressed in Cerebrospinal fluid of Creutzfeldt-Jacob disease patients: a MALDI-TOF MS protein profiling study. 49
An SNP site in pri-miR-124, a brain expressed miRNA gene, no contribution to mesial temporal lobe epilepsy in an Italian sample 49
Totale 6.263
Categoria #
all - tutte 73.786
article - articoli 53.332
book - libri 81
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 243
Totale 127.442


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024130 0 0 0 0 0 0 0 0 11 0 80 39
2024/20258.684 34 30 734 369 2.171 179 140 202 231 367 2.187 2.040
2025/202613.368 691 1.386 1.175 2.020 2.484 562 2.072 662 890 832 476 118
Totale 22.182